Narrative review / 2018
High serum homocysteine, elevated in vitamin B or folate deficiency, may be a factor that reduces bone mass and impairs bone quality.
This review outlines the epidemiology and pathophysiology of osteoporosis linked to hyperhomocysteinemia. Serum homocysteine increases in individuals with vitamin B or folate deficiency or MTHFR (C677T: TT type) polymorphisms. High homocysteine is shown to have detrimental effects on osteoblasts and osteoclasts, increase oxidative stress, disrupt collagen cross-linking, and elevate advanced glycation end products, resulting in reduced bone strength. Consequently, high serum homocysteine may be regarded as a factor that can reduce bone mass and impair bone quality.
- Study type
- Narrative review
- Who was studied
- Individuals with homocystinuria or vitamin B/folate deficiency
- What was measured
- Osteoporosis, bone mass, bone quality, and bone strength
THE PAPER
The Effects of Homocysteine on the Skeleton.
Saito M, Marumo K. Curr Osteoporos Rep, 2018.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.